Main Subject - Internet and Businesses Online

My best guess to you would be to be careful how you use these swaps. Gene

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

rally shoot to do these mailings with people who have roughly the same num

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

er of subscribers as you do, or more. This way you can almost guarantee t

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

hat the gain you get is at least as great as what you lose.

So how do you

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

find JV partners like this?

First of all, anyone who emails you regularly

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

, and you approve of his mailings, makes a good candidate for a swap. If

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ou are not on many mailing lists, get on a few. The easiest way to do tha

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

t is to do a search engine search for your niche, click into the web pages

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

and sign up for every opt in email list that you can. If you do not like

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

getting a lot of mail, set up a separate email address for these emails.

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

You will get a lot of email over time if you sign up for a lot of newslett

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

rs and opt in email lists. But the advantage is that when you are ready t

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

o do some swaps, you will have a ready list of people who are active list

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

builders, to ask to do a swap.

This is the email request letter I use whe

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

n emailing each of the list builders who email me:

Subject line: Inter

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

sted in doing a mailing swap?

Dear (name):

I won't waste your time here.

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

.

I am on your list and have been for some time now, and it looks like yo

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

have about the same demographic on your list as I have on mine.

Would yo

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

u be interested in mailing an offer to my list, in exchange for my doing t

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

e same with your list?

If that is of interest to you, just let me know

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Main Subject - List Building With JV Partners II

Related Articles: